AMBFX
Price
$35.61
Change
-$0.31 (-0.86%)
Updated
Jun 13 closing price
Net Assets
244.39B
VPRAX
Price
$29.41
Change
-$0.23 (-0.78%)
Updated
Jun 13 closing price
Net Assets
6.69B
Interact to see
Advertisement

AMBFX vs VPRAX

Header iconAMBFX vs VPRAX Comparison
Open Charts AMBFX vs VPRAXBanner chart's image
American Funds American Balanced F2
Price$35.61
Change-$0.31 (-0.86%)
VolumeN/A
Net Assets244.39B
VY® T. Rowe Price Capital Apprec R6
Price$29.41
Change-$0.23 (-0.78%)
VolumeN/A
Net Assets6.69B
AMBFX vs VPRAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMBFX vs. VPRAX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMBFX is a Buy and VPRAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AMBFX has more cash in the bank: 244B vs. VPRAX (6.69B). VPRAX pays higher dividends than AMBFX: VPRAX (2.85) vs AMBFX (2.13). AMBFX was incepted earlier than VPRAX: AMBFX (17 years) vs VPRAX (9 years). VPRAX (0.65) is less costly to investors than AMBFX (0.35). VPRAX is a more actively managed with annual turnover of: 84.00 vs. AMBFX (44.00). VPRAX has a lower initial minimum investment than AMBFX: VPRAX (0) vs AMBFX (250). VPRAX annual gain was more profitable for investors over the last year : 8.86 vs. AMBFX (5.53). AMBFX return over 5 years is better than : 39.71 vs. VPRAX (9.77).
AMBFXVPRAXAMBFX / VPRAX
Total Expense Ratio0.350.6554%
Annual Report Gross Expense Ratio0.350.6554%
Fund Existence17 years9 years-
Gain YTD4.5414.069112%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets244B6.69B3,649%
Annual Yield % from dividends2.132.8575%
Returns for 1 year5.538.8662%
Returns for 3 years33.4712.71263%
Returns for 5 years39.719.77406%
Returns for 10 years59.88N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSTL18.75-0.07
-0.37%
Castle Biosciences
KAVL0.53-0.01
-1.67%
Kaival Brands Innovations Group
CBU55.13-1.52
-2.68%
Community Financial System Inc
CX6.77-0.22
-3.15%
Cemex SAB de CV
TARA3.14-0.12
-3.68%
Protara Therapeutics